News

The Wolvetang laboratory at AIBN recently found that key areas of the brain affected in this disease can be recreated in the lab using patient-derived stem cells, and this has now been published in the journal Frontiers in Cellular Neuroscience.

The Australian Research Council Training Centre for Biopharmaceutical Innovation (CBI), will receive $110,000 in provisional funding for a major training program.

Associate Professor Jessica Mar has received a $50,000 Metcalf Prize from the National Stem Cell Foundation of Australia in recognition of her leadership in stem cell research.

The AIBN Student Association (ASA) won the 2017 Postgraduate Club of the Year award at the UQ Union Clubs and Societies Gala.

AIBN’s Level 5 floor manager Dr Colette Godfrey has raised over $900 for the Ovarian Cancer Research Foundation (OCRF) as part of their annual frocktober campaign.

The 2017 International Conference on BioNano Innovation (ICBNI 2017) will be held from the 24th-27th September (registration closes Friday 15/09)

AIBN Researchers and US company LanzaTech have developed a computer model that harnesses ancient biology for carbon-capture biotechnology. 

Professor Lianzhou Wang teamed up with researchers in academia and industry to develop printed flexible batteries.

Imagination and creativity play an important role in scientific research, so it’s no surprise to that AIBN is not only home to great scientists, but also a number of wonderful artists.

The AIBN IT team received recognition for their hard work and expertise at the 2017 UQ Awards for Excellence

Our fleet footed runners Ariane Mora, Lewis Chambers, Irene Reto and Nick Hong Seng Lee are now the reigning 2017 Great Court Race Mixed Staff Relay champions!

Drugs disguised as viruses are providing new weapons in the battle against cancer, promising greater accuracy and fewer side effects than chemotherapy

A new research study is looking to improve the lives of people with diabetes by developing a matchstick-size nano-implant that removes the need for daily insulin injections.

A researcher from The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has received a joint appointment as the leader of a new initiative of CSIRO.

Start-up company Scaled Biolabs Inc is changing the way researchers around the world conduct manual cellular experiments and accelerating discoveries in biology by providing novel devices that enable 1000’s of experiments to occur simultaneously.

Patients at risk of life-threatening infections following chemotherapy could benefit from a new cell-based treatment developed from University of Queensland research.

The University of Queensland’s Australian Institute for Bioengineering and Nanotechnologywill host leading scientists from across the world at the International Conference on BioNano Innovation (ICBNI) in September next year.

New research findings from The University of Queensland have revealed that hollow nanospheres made from iron oxide hold promise as an antibacterial agent to fight diseases caused by microbial infections.

The University of Queensland today launched a new $7 million regenerative medicine research centre to improve older Australians’ quality of life and increase their participation and productivity.

Researchers at The University of Queensland are developing a vaccine to reduce the staggering level of infant mortality from rotavirus in developing countries by significantly decreasing the cost of vaccine production and logistics.